Oct 27 (Reuters) - Medical Developments International Ltd MVP.AX :
* Penthrox receives regulatory & marketing approval in the UK
* Says MVP expects first sales to be in January 2016 for penthrox
* "Expect sales to commence in France and Belgium during H2 FY16 once approval in France is granted"
* Licensing and supply agreement with MVP
* "Once approval from France is receipted Mundipharma will pay MVP a further milestone payment of USD $3MLN"
* Mhra approval means galen will pay mvp another milestone payment of GBP £450,000, MVP will receive this in 1H FY 2016
* "Expect significant sales to be made in 2h FY 2016 and beyond" for penthrox
Source text for Eikon ID:nASX1NF792